Dr. Reddy’s to Drop “Olymviq” After Court Order, Gets 30 Days to Clear Stock
A recent trademark dispute between Dr. Reddy’s Laboratories and Novo Nordisk has led to significant changes in branding strategy, impacting the rapidly growing semaglutide drug market in India. Following the Delhi High Court’s recording of the company’s commitment to stop using the name in a trademark dispute with Novo Nordisk, Dr. Reddy’s Laboratories will have … Read more